Martin Larsson

Publications
CV
Public outreach and news

Articles

Article: BRITISH JOURNAL OF PHARMACOLOGY. 2022;179(4):677-694
Normalisation of glucose metabolism by exendin-4 in the chronic phase after stroke promotes functional recovery in male diabetic mice
Augestad IL; Dekens D; Karampatsi D; Elabi O; Zabala A; Pintana H; Larsson M; Nystrom T; Paul G; Darsalia V; Patrone C
Article: DIABETES. 2020;69(9):1961-1973
Regulation of Glycemia in the Recovery Phase After Stroke Counteracts the Detrimental Effect of Obesity-Induced Type 2 Diabetes on Neurological Recovery
Augestad IL; Pintana H; Larsson M; Krizhanovskii C; Nystrom T; Klein T; Darsalia V; Patrone C
Article: ACTA NEUROLOGICA SCANDINAVICA. 2019;140(6):443-448
Prehospital exenatide in hyperglycemic stroke-A randomized trial
Larsson M; Castren M; Lindstrom V; von Euler M; Patrone C; Wahlgren N; Nathanson D
Article: CARDIOVASCULAR DIABETOLOGY. 2019;18(1):91
GLP-1 secretion in acute ischemic stroke: association with functional outcome and comparison with healthy individuals
Larsson M; Patrone C; von Euler M; Holst JJ; Nathanson D
Article: BMJ OPEN. 2017;7(10):e016311
Safety of thrombolysis in stroke mimics: an observational cohort study from an urban teaching hospital in Sweden
Kostulas N; Larsson M; Kall T-B; von Euler M; Nathanson D
Article: BIOSCIENCE REPORTS. 2016;36(6):e00421
Diabetes negatively affects cortical and striatal GABAergic neurons: an effect that is partially counteracted by exendin-4
Larsson M; Lietzau G; Nathanson D; Ostenson C-G; Mallard C; Johansson ME; Nystrom T; Patrone C; Darsalia V
Article: DIABETES, OBESITY AND METABOLISM. 2016;18(5):537-541
Gliptin-mediated neuroprotection against stroke requires chronic pretreatment and is independent of glucagon-like peptide-1 receptor
Darsalia V; Larsson M; Lietzau G; Nathanson D; Nystrom T; Klein T; Patrone C
Article: REGULATORY PEPTIDES. 2014;190:25-31
Linagliptin enhances neural stem cell proliferation after stroke in type 2 diabetic mice
Darsalia V; Olverling A; Larsson M; Mansouri S; Nathanson D; Nystrom T; Klein T; Sjoholm A; Patrone C
Article: PLOS ONE. 2014;9(8):e103114
Exendin-4 Reduces Ischemic Brain Injury in Normal and Aged Type 2 Diabetic Mice and Promotes Microglial M2 Polarization
Darsalia V; Hua S; Larsson M; Mallard C; Nathanson D; Nystroem T; Sjoeholm A; Johansson ME; Patrone C
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2010;48(10):3810-3812
Polymicrobial Bloodstream Infection with Eggerthella lenta and Desulfovibrio desulfuricans
Liderot K; Larsson M; Borang S; Ozenci V

All other publications

Thesis / dissertation: 2019
Save the brain! Studies on GLP-1-mediated neuroprotection
Larsson, Martin
Corrigendum: DIABETES, OBESITY AND METABOLISM. 2018;20(4):1086
Gliptin-mediated neuroprotection against stroke requires chronic pretreatment and is independent of glucagon-like peptide-1 receptor (vol 18, pg 537, 2016)
Darsalia V; Larsson M; Lietzau G; Nathanson D; Nystrom T; Klein T; Patrone C
Editorial comment: CARDIOVASCULAR DIABETOLOGY. 2018;17(1):32
The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors
Darsalia V; Larsson M; Klein T; Patrone C
Review: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2015;35(5):718-723
Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke
Darsalia V; Larsson M; Nathanson D; Klein T; Nystrom T; Patrone C

Employments

Affiliated to Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, 2023-2026

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, 2019
University Medical Degree, Karolinska Institutet, 2006

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI